Atossa Therapeutics Inc

ATOSNASDAQ · USD
2.22USD0.00 (-7.50%)
122

Atossa Therapeutics Inc (ATOS) Option Chain

As of September 18, 2026, Atossa Therapeutics Inc is trading at $2.22, a -7.50% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 126.5%. IV Rank is 37%.

Read more

Tracking the ATOS option chain helps you see every strike and expiry on Atossa Therapeutics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Atossa Therapeutics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ATOS options activity at a glance. Use our scanner to monitor the ATOS option chain in real time and filter for the ATOS options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ATOS stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ATOS option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ATOS stock options are being actively traded and where they are not.

Atossa Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc.

was founded in 2008 and is based in Seattle, Washington.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Atossa Therapeutics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen ATOS options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ATOS stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile56.35% Neutral
  • Market cap (M$)22
  • 52 weeks high-88.53%
  • 52 weeks low30.59%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$14.33
    545.50% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-11
  • P/E
  • Future P/E
  • EPS (ttm)-4.34
  • EPS growth next 5 years

As of September 18, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
1.59000.181.220.901.901.00-54.950.200.000.2001298.41
44.514910.300.220.100.952.00-9.910.200.000.200455.49
84.9915400.130.000.050.203.00+35.140.301.200.78-0.030015.01
96.923300.250.000.254.00+80.181.202.151.78-0.10043.08
99.411600.500.000.505.00+125.232.203.202.78-0.08010.59

As of September 18, 2026

Scan the full option chain in one place

Browse the full ATOS option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial